Literature DB >> 12773674

Conventional radiography, rapid MR imaging, and conventional MR imaging for low back pain: activity-based costs and reimbursement.

Darryl T Gray1, William Hollingworth, C Craig Blackmore, Michael A Alotis, Brook I Martin, Sean D Sullivan, Richard A Deyo, Jeffrey G Jarvik.   

Abstract

PURPOSE: To incorporate personnel and equipment use time in an activity-based cost comparison of conventional radiography and conventional and rapid magnetic resonance (MR) imaging for low back pain (LBP).
MATERIALS AND METHODS: At each of four Seattle Lumbar Imaging Project (SLIP) sites, patients were randomized to undergo conventional radiography or rapid MR imaging of the lumbar spine. For sample SLIP patients and for similar non-SLIP patients undergoing conventional lumbar spine MR imaging as usual care in calendar year 2000, measured imaging room use and technologist and radiologist times were multiplied by costs per minute of standard equipment acquisition, personnel compensation, and related expenses. Resulting provider-perspective costs and Seattle area Medicare reimbursements for conventional MR imaging and radiography for calendar year 2001 were used to estimate future "normative" reimbursement for rapid MR imaging.
RESULTS: For 23 conventional radiography, 27 rapid MR imaging, and 38 conventional MR imaging examinations timed in calendar year 2000, all rapid MR imaging times exceeded those of conventional radiography but were less than those of conventional MR imaging. All 0.3- and 0.35-T MR imaging room and technologist times exceeded those for 1.5-T MR imaging. Average costs (in 2001 dollars) were $44 for conventional radiography, 126 US dollars for 1.5-T rapid MR imaging, 128 US dollars for 0.3-0.35-T rapid MR imaging, 267 US dollars for 1.5-T conventional MR imaging, and 264 US dollars for 0.3-0.35-T conventional MR imaging. Conclusions regarding cost differences between conventional radiography and rapid MR imaging were robust to plausible parameter value changes evaluated in sensitivity analyses. Conventional radiography reimbursement was 44 US dollars. Applying the ratio of reimbursement (620 US dollars) to costs (264-267 US dollars) for conventional MR imaging to rapid MR imaging costs predicted reimbursement of 292-300 US dollars for the new modality.
CONCLUSION: Times and costs for rapid MR imaging are roughly three times those for conventional radiography but about half those for conventional MR imaging for LBP. While current conventional radiography costs exceed reimbursement, current conventional MR and projected rapid MR imaging reimbursements exceed costs.

Entities:  

Mesh:

Year:  2003        PMID: 12773674     DOI: 10.1148/radiol.2273012213

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Rapid magnetic resonance imaging for diagnosing cancer-related low back pain.

Authors:  William Hollingworth; Darryl T Gray; Brook I Martin; Sean D Sullivan; Richard A Deyo; Jeffrey G Jarvik
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

2.  Limited magnetic resonance imaging of the lumbar spine has high sensitivity for detection of acute fractures, infection, and malignancy.

Authors:  Benjamin Wang; Florian J Fintelmann; Ravi S Kamath; Susan V Kattapuram; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2016-10-10       Impact factor: 2.199

3.  Costs and state-specific rates of thoracic and lumbar vertebroplasty, 2001-2005.

Authors:  Darryl T Gray; William Hollingworth; Nneka Onwudiwe; Jeffrey G Jarvik
Journal:  Spine (Phila Pa 1976)       Date:  2008-08-01       Impact factor: 3.468

4.  Achieving Value in Spine Surgery: 10 Major Cost Contributors.

Authors:  Lucas R Philipp; Adam Leibold; Aria Mahtabfar; Thiago S Montenegro; Glenn A Gonzalez; James S Harrop
Journal:  Global Spine J       Date:  2021-04

5.  The use of risk sharing tools for post adoption surveillance of a non pharmacological technology in routine practice: results after one year.

Authors:  Carlos Campillo-Artero; Francisco M Kovacs
Journal:  BMC Health Serv Res       Date:  2013-05-20       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.